ACEA Biosciences Overview
- Year Founded
-
2002

- Status
-
Acquired/Merged
- Employees
-
201

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$250M
ACEA Biosciences General Information
Description
Developer of cell analysis instruments designed to help in life science research and clinical diagnostics. The company's instruments use microelectrodes in automated high-throughput plate formats to offer real time cell analysis, enabling doctors to monitor cell proliferation, cell size, cell-substrate attachment quality and cell invasion easily.
Contact Information
Website
www.aceabio.comCorporate Office
- 6779 Mesa Ridge Road
- Suite 100
- San Diego, CA 92121
- United States
Corporate Office
- 6779 Mesa Ridge Road
- Suite 100
- San Diego, CA 92121
- United States
ACEA Biosciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Merger/Acquisition | 14-Nov-2018 | $250M | Completed | Generating Revenue | ||
6. Later Stage VC (Series E) | 01-Apr-2016 | Completed | Generating Revenue | |||
5. Grant | 03-Jul-2013 | Completed | Generating Revenue | |||
4. Later Stage VC (Series D) | 10-Sep-2007 | Completed | Generating Revenue | |||
3. Later Stage VC (Series C) | Completed | Generating Revenue | ||||
2. Early Stage VC (Series B) | $1.85M | $4.15M | Completed | Generating Revenue | ||
1. Early Stage VC (Series A) | $2.3M | $2.3M | Completed | Generating Revenue |
ACEA Biosciences Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series E | ||||||||
Series D | ||||||||
Series C | ||||||||
Series B | 1,589,690 | $0.001000 | 4% | $1.16 | $1.16 | 1x | $1.16 | 7.98% |
Series A | 3,199,414 | $0.001000 | 4% | $0.95 | $0.95 | 1x | $0.95 | 16.06% |
ACEA Biosciences Comparisons
Industry
Financing
Details
ACEA Biosciences Competitors (22)
One of ACEA Biosciences’s 22 competitors is Illumina, a Formerly VC-backed company based in San Diego, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Illumina | Formerly VC-backed | San Diego, CA | ||||
Sphere Fluidics | Venture Capital-Backed | Cambridge, United Kingdom | ||||
Active Motif | Private Equity-Backed | Carlsbad, CA | ||||
Aviva Systems Biology | Formerly VC-backed | San Diego, CA | ||||
Cytena | Formerly VC-backed | Freiburg, Germany |
ACEA Biosciences Patents
ACEA Biosciences Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
JP-2019527839-A | Optical detection system for flow cytometer, flow cytometer system and method of use | Active | 15-Jul-2016 | ||
EP-3071951-A4 | Optical engine for flow cytometer, flow cytometer system and methods of use | Active | 19-Nov-2013 | ||
EP-3071951-B1 | Optical engine for flow cytometer, flow cytometer system and methods of use | Active | 19-Nov-2013 | ||
EP-3071951-A2 | Optical engine for flow cytometer, flow cytometer system and methods of use | Active | 19-Nov-2013 | ||
CA-2917364-C | Heterocyclic compounds and uses thereof | Active | 11-Jul-2013 | C07D417/12 |
ACEA Biosciences Signals
ACEA Biosciences Former Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Lilly Asia Ventures | Corporate Venture Capital | Minority | ||
Qiming Venture Partners | Venture Capital | Minority | ||
U.S. Environmental Protection Agency | Government |
ACEA Biosciences FAQs
-
When was ACEA Biosciences founded?
ACEA Biosciences was founded in 2002.
-
Where is ACEA Biosciences headquartered?
ACEA Biosciences is headquartered in San Diego, CA.
-
What is the size of ACEA Biosciences?
ACEA Biosciences has 201 total employees.
-
What industry is ACEA Biosciences in?
ACEA Biosciences’s primary industry is Other Devices and Supplies.
-
Is ACEA Biosciences a private or public company?
ACEA Biosciences is a Private company.
-
What is the current valuation of ACEA Biosciences?
The current valuation of ACEA Biosciences is
. -
What is ACEA Biosciences’s current revenue?
The current revenue for ACEA Biosciences is
. -
How much funding has ACEA Biosciences raised over time?
ACEA Biosciences has raised $42.8M.
-
Who are ACEA Biosciences’s investors?
Lilly Asia Ventures, Qiming Venture Partners, and U.S. Environmental Protection Agency have invested in ACEA Biosciences.
-
Who are ACEA Biosciences’s competitors?
Illumina, Sphere Fluidics, Active Motif, Aviva Systems Biology, and Cytena are some of the 22 competitors of ACEA Biosciences.
-
When was ACEA Biosciences acquired?
ACEA Biosciences was acquired on 14-Nov-2018.
-
Who acquired ACEA Biosciences?
ACEA Biosciences was acquired by Agilent Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »